Liver-directed therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Liver-directed therapy, covering 2026-08-28 to 2026-08-28. Get the full timeline:
Most recent: Clinical Trial Results: Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases [Phase 2]